S. A. Plotkin

3.2k total citations
55 papers, 2.3k citations indexed

About

S. A. Plotkin is a scholar working on Epidemiology, Infectious Diseases and Immunology. According to data from OpenAlex, S. A. Plotkin has authored 55 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Epidemiology, 25 papers in Infectious Diseases and 10 papers in Immunology. Recurrent topics in S. A. Plotkin's work include Cytomegalovirus and herpesvirus research (20 papers), Herpesvirus Infections and Treatments (17 papers) and Viral gastroenteritis research and epidemiology (12 papers). S. A. Plotkin is often cited by papers focused on Cytomegalovirus and herpesvirus research (20 papers), Herpesvirus Infections and Treatments (17 papers) and Viral gastroenteritis research and epidemiology (12 papers). S. A. Plotkin collaborates with scholars based in United States, France and Canada. S. A. Plotkin's co-authors include Stuart E. Starr, H. F. Clark, Louis M. Bell, Éva Gönczöl, Harvey M. Friedman, J. W. Farquhar, N. Zygraich, Paul A. Offit, Vera Gouvêa and S. Hempfling and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Annals of Internal Medicine.

In The Last Decade

S. A. Plotkin

54 papers receiving 2.2k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
S. A. Plotkin 1.5k 1.1k 347 324 314 55 2.3k
Shin Isomura 1.3k 0.9× 999 0.9× 477 1.4× 547 1.7× 181 0.6× 81 2.4k
Takao Ozaki 2.0k 1.4× 844 0.7× 166 0.5× 346 1.1× 152 0.5× 116 2.6k
M. Parea 1.0k 0.7× 703 0.6× 291 0.8× 210 0.6× 173 0.6× 35 1.5k
Elisabeth Puchhammer‐Stöckl 1.8k 1.2× 1.4k 1.2× 360 1.0× 615 1.9× 400 1.3× 136 3.6k
Jolanta Kurz 1.0k 0.7× 985 0.9× 199 0.6× 217 0.7× 170 0.5× 11 2.5k
Antonella Sarasini 3.5k 2.3× 2.4k 2.1× 596 1.7× 447 1.4× 442 1.4× 108 4.7k
June D. Almeida 1.3k 0.9× 1.1k 0.9× 122 0.4× 504 1.6× 290 0.9× 93 2.9k
Linda L. Yasukawa 1.4k 1.0× 910 0.8× 190 0.5× 222 0.7× 493 1.6× 38 2.1k
Juan E. Echevarrı́a 1.3k 0.9× 1.5k 1.3× 517 1.5× 161 0.5× 206 0.7× 129 3.1k
Anna Maria Eis‐Hübinger 1.4k 1.0× 1.6k 1.4× 319 0.9× 283 0.9× 572 1.8× 102 3.5k

Countries citing papers authored by S. A. Plotkin

Since Specialization
Citations

This map shows the geographic impact of S. A. Plotkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. A. Plotkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. A. Plotkin more than expected).

Fields of papers citing papers by S. A. Plotkin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. A. Plotkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. A. Plotkin. The network helps show where S. A. Plotkin may publish in the future.

Co-authorship network of co-authors of S. A. Plotkin

This figure shows the co-authorship network connecting the top 25 collaborators of S. A. Plotkin. A scholar is included among the top collaborators of S. A. Plotkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. A. Plotkin. S. A. Plotkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Permar, Sallie R., Mark R. Schleiss, & S. A. Plotkin. (2025). A vaccine against cytomegalovirus: how close are we?. Journal of Clinical Investigation. 135(1). 12 indexed citations
2.
Loomis, Rebecca J., Yen‐Ting Lai, Sun B. Sowers, et al.. (2024). Structure-based design of glycoprotein subunit vaccines for mumps. Proceedings of the National Academy of Sciences. 121(47). e2404053121–e2404053121. 1 indexed citations
3.
Schleiss, Mark R., et al.. (2024). Proceedings of the Conference “CMV Vaccine Development—How Close Are We?” (27–28 September 2023). Vaccines. 12(11). 1231–1231. 7 indexed citations
4.
Plotkin, S. A.. (2013). Complex Correlates of Protection After Vaccination. Clinical Infectious Diseases. 56(10). 1458–1465. 181 indexed citations
5.
Gellin, Bruce G., John F. Modlin, & S. A. Plotkin. (2001). CHAT Oral Polio Vaccine Was Not the Source of Human Immunodeficiency Virus Type 1 Group M for Humans. Clinical Infectious Diseases. 32(7). 1068–1084. 12 indexed citations
6.
Clark, H. F., Paul A. Offit, Ronald W. Ellis, et al.. (1996). The Development Of Multivalent Bovine Rotavirus (Strain Wc3) Reassortant. The Journal of Infectious Diseases. 174(Supplement 1). S73–S80. 157 indexed citations
7.
Wang, Jinbao, S. P. Adler, S. Hempfling, et al.. (1996). Mucosal Antibodies to Human Cytomegalovirus Glycoprotein B Occur following both Natural Infection and Immunization with Human Cytomegalovirus Vaccines. The Journal of Infectious Diseases. 174(2). 387–392. 48 indexed citations
8.
Adler, S. P., Stuart E. Starr, S. A. Plotkin, et al.. (1995). Immunity Induced By Primary Human Cytomegalovirus Infection Protects Against Secondary Infection Among Women Of Childbearing Age. The Journal of Infectious Diseases. 171(1). 26–32. 191 indexed citations
9.
Plotkin, S. A.. (1993). Vaccination in the 21st Century. The Journal of Infectious Diseases. 168(1). 29–37. 17 indexed citations
10.
11.
Plotkin, S. A., Stuart E. Starr, Harvey M. Friedman, et al.. (1991). Effect of Towne Live Virus Vaccine on Cytomegalovirus Disease after Renal Transplant. Annals of Internal Medicine. 114(7). 525–531. 155 indexed citations
12.
Kawashima, Hisashi, Santu Bandyopadhyay, Richard M. Rutstein, & S. A. Plotkin. (1991). Excretion of human immunodeficiency type 1 in the throat but not in urine by infected children. The Journal of Pediatrics. 118(1). 80–82. 9 indexed citations
13.
Starr, Stuart E., Harvey M. Friedman, & S. A. Plotkin. (1991). The Status of Cytomegalovirus Vaccine. Clinical Infectious Diseases. 13(Supplement_11). S964–S965. 8 indexed citations
14.
Ho, Wen‐Zhe, Janet M. Harouse, Robert F. Rando, et al.. (1990). Reciprocal Enhancement of Gene Expression and Viral Replication Between Human Cytomegalovirus and Human immunodeficiency Virus Type 1. Journal of General Virology. 71(1). 97–103. 84 indexed citations
15.
Plotkin, S. A., Robert S. Daum, G. Scott Giebink, et al.. (1989). Haemophilus influenzae type b conjugate vaccines: Update. PEDIATRICS. 84(2). 386–387. 8 indexed citations
16.
Plotkin, S. A., Robert S. Daum, G. Scott Giebink, et al.. (1989). Measles: Reassessment of the current immunization policy. PEDIATRICS. 84(6). 1110–1113. 70 indexed citations
17.
Plotkin, S. A., et al.. (1989). Protective Effects of Towne Cytomegalovirus Vaccine Against Low-Passage Cytomegalovirus Administered as a Challenge. The Journal of Infectious Diseases. 159(5). 860–865. 138 indexed citations
18.
Gönczöl, Éva, et al.. (1989). Humoral Immune Response to Cytomegalovirus Towne Vaccine Strain and to Toledo Low-Passage Strain. The Journal of Infectious Diseases. 159(5). 851–859. 27 indexed citations
19.
Plotkin, S. A., Robert S. Daum, G. Scott Giebink, et al.. (1988). Haemophilus influenzae type b conjugate vaccine. PEDIATRICS. 81(6). 908–911. 18 indexed citations
20.
Clark, H. F., et al.. (1988). Protective Effect of WC3 Vaccine Against Rotavirus Diarrhea in Infants During a Predominantly Serotype 1 Rotavirus Season. The Journal of Infectious Diseases. 158(3). 570–587. 201 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shin Isomura Breakdown of academic impact, for papers by Takao Ozaki Breakdown of academic impact, for papers by M. Parea Breakdown of academic impact, for papers by Elisabeth Puchhammer‐Stöckl Breakdown of academic impact, for papers by Jolanta Kurz Breakdown of academic impact, for papers by Antonella Sarasini Breakdown of academic impact, for papers by June D. Almeida Breakdown of academic impact, for papers by Linda L. Yasukawa Breakdown of academic impact, for papers by Juan E. Echevarrı́a Breakdown of academic impact, for papers by Anna Maria Eis‐Hübinger
Rankless by CCL
2026